In the name of Working group of the bioregions of Germany (AK-BioRegions) wants that BioRN Life Science Cluster Rhine-Neckar this year virtual presentation of the EY Biotech Report on Tuesday, July 13.07.2021, 15 at XNUMX p.m
During the pandemic, the innovative strength of German biotech companies in particular became impressively visible. It showed that this industry can show the way out of the crisis through tests, diagnostics, therapies and vaccines. Biotechnology has thus become the focus of attention - in society, in politics, the media and among investors. In many areas, the sector was able to develop new dynamics and achieve records in financing, in turnover, in the number of employees and in expenditure on research and development. Biotechnology is thus at a turning point, at a "tipping point", as described in EY's German Biotechnology Report 2021. The central question: In which direction will the sector develop after the pandemic? The report provides the answers. It shows which opportunities are now arising, which new challenges are arising and what needs to be done in order to use the momentum in the long term.
Program, moderated by Julia Schaft, Managing Director, BioRN:
We ask that you find out about this Link to register for free. You will receive the access data shortly before the event.
Also this year, the University of Leipzig - this time together with the Max Planck Institute for Mathematics in the Natural Sciences Leipzig - raised the most valuable research prize in Germany: The expert for artificial intelligence (AI), Prof. Dr. Sayan Mukherjee, will be the new Alexander von Humboldt Professor in 2022.
The industry association biosaxony e. V. is launching a digital campaign on June 22, 2021 to honor the commitment of Saxon biotech and medtech companies.